2003
DOI: 10.2337/diabetes.52.5.1104
|View full text |Cite
|
Sign up to set email alerts
|

Adipose Tissue Is a Major Source of Interleukin-1 Receptor Antagonist

Abstract: The secreted form of the interleukin-1 receptor antagonist (IL-1Ra) is an acute-phase protein intervening in the counterregulation of inflammatory processes. We previously showed that this cytokine antagonist is upregulated in the serum of obese patients, correlating with BMI and insulin resistance. In this study, we examined the expression pattern of IL-1Ra and showed that it is highly expressed not only in liver and spleen, but also in white adipose tissue (WAT), where it is upregulated in obesity. In WAT of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

20
194
6
3

Year Published

2006
2006
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 262 publications
(223 citation statements)
references
References 30 publications
(18 reference statements)
20
194
6
3
Order By: Relevance
“…PPARγ is stimulated during adipocyte differentiation, and is also involved in the resolution of inflammation in many other cell types, in which it downregulates levels of inflammatory proteins, such as COX-2 and IL-1β. In fact, the expression pattern of IL-33 was more similar to that of IL-1 receptor antagonist, the natural inhibitor of IL-1β, which is also expressed in non-inflammatory bone [41] and in adipocytes (our unpublished data and [42]). It will be interesting to examine whether the expression of IL-33, like that of IL-1Ra, is also controlled by PPARα [43,44] and PPARβ/δ [45].…”
Section: Discussionmentioning
confidence: 58%
“…PPARγ is stimulated during adipocyte differentiation, and is also involved in the resolution of inflammation in many other cell types, in which it downregulates levels of inflammatory proteins, such as COX-2 and IL-1β. In fact, the expression pattern of IL-33 was more similar to that of IL-1 receptor antagonist, the natural inhibitor of IL-1β, which is also expressed in non-inflammatory bone [41] and in adipocytes (our unpublished data and [42]). It will be interesting to examine whether the expression of IL-33, like that of IL-1Ra, is also controlled by PPARα [43,44] and PPARβ/δ [45].…”
Section: Discussionmentioning
confidence: 58%
“…Human and rodent WAT is a major source of IL1RN [43,44]. Il1rn −/− mice, in which excess IL1 signalling may be induced, show a lean phenotype [45].…”
Section: Discussionmentioning
confidence: 99%
“…30 White adipose tissue (WAT) is a major source of leptin and IL-1Ra in humans and rodents and the expression of these cytokines is markedly upregulated in obese WAT. 21,31 The macrophage content of WAT is significantly increased in obesity, mediated partly through increased infiltration of circulating macrophages, and this is thought to be a mechanism contributing to elevated cytokine levels. 32 Supporting this, leptin produced by adipocytes stimulates IL-1Ra production by monocytes, through binding to leptin receptors expressed on these cells.…”
Section: Discussionmentioning
confidence: 99%